Here's Why Immunomedics Fell as Much as 10.8% Today

What happened Shares of Immunomedics NASDAQ IMMU fell nearly 11 today after the company reported fiscal first quarter 2019 operating results Immunomedics is a pre commercial business so there s not much for investors to peer into except perhaps the magnitude of

http://articlefeeds.nasdaq.com/~r/nasdaq/categories/~3/LmyAeB7jlhE/heres-why-immunomedics-fell-as-much-as-108-today-cm1053178